IL10 and malaria: The subgroup analysis of the study design showed no difference in the IL-10 levels between patients with severe and non-severe malaria in all types of study designs, indicating that the study design did influence the pooled effect estimate, and the study design was not the source of the heterogeneity of the meta-analysis outcome.